On 20 November 2024, Union Minister of Science and Technology, Dr. Jitendra Singh, launched Nafithromycin, India’s first indigenous antibiotic, to combat drug-resistant infections. Speaking at the launch event in New Delhi, he highlighted that the three-day treatment regimen of Nafithromycin is a breakthrough in addressing drug-resistant pneumonia, a condition causing over two million deaths annually.
Developed with support from the Biotechnology Industry Research Assistance Council (BIRAC), under the Department of Biotechnology, the drug is marketed under the trade name Miqnaf. This Made-in-India antibiotic is a significant step in tackling Antimicrobial Resistance (AMR), marking a milestone in India’s pharmaceutical innovation.
